- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06414213
Improving Locomotor Learning With Brain Stimulation (ELLMITS)
May 9, 2024 updated by: Jared Skinner, Appalachian State University
Enhancing Locomotor Learning With Motor Imagery and Transcranial Direct Current Stimulation
The primary goal of this research was to assess the practicality and initial effectiveness of a motor imagery (MI) intervention combined with elements of action observation (AO), alongside active or sham transcranial direct current stimulation (tDCS) over the prefrontal cortex (PFC), on locomotor learning in healthy adults.
Feasibility was determined by examining recruitment rates, participant engagement, and safety measures.
The efficacy of the intervention was gauged by analyzing the time taken to complete tasks and changes in cerebral blood flow immediately after the intervention and one week later.
The study was guided by three main hypotheses: (1) the intervention techniques would be well-received and safe for the participants; (2) compared to a control group, MI training would lead to better learning outcomes and retention of learning; (3) in comparison to the control and sham tDCS groups, active tDCS would result in superior learning outcomes and retention of learning.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study implemented a double-blind, randomized, controlled trial design.
Participants were tested three times over 7 days.
After study enrollment, the participants were randomly assigned to one of three groups: MIActive (receiving active tDCS stimulation and participating in MI protocol), MISham (receiving sham tDCS stimulation and participating in MI protocol), and Control (receiving no stimulation and participating in an unrelated video-watching task) by a research member not associated with data collection.
Allocation ratio was 1:1:1 and a block randomization approach was employed to maintain an equal distribution of participants across the three groups throughout the study.
Study participants and assessors were blinded to assignment of active or sham tDCS.
The independent variables were time (pre, post, and retention trials) and group (MIActive, MISham and Control), and the dependent variables were time to completion of a complex obstacle course and the amount of change in oxygenated hemoglobin (ΔO2Hb) during performance of that task.
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Boone, North Carolina, United States, 28607
- Appalachian State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Male and female adults age 18 and older
- Freely ambulatory (no assistive walking aids)
Exclusion Criteria:
- Failure to meet specific inclusion criteria
- History or presence of any neurological disease
- Low visual ability, operationally defined as visual acuity less than 20/70 on the standard eye chart
- Extreme difficulty performing walking tasks due to low visual ability
- Clinical judgment of the investigative team
- Additionally, subjects who are determined to be at increased risk for adverse events during the tDCS procedure, as determined by the tDCS screening questionnaire
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: MI/Active tDCS
The participants received active tDCS current and participated in the Motor Imagery intervention.
|
Participants watched a standardized video sequence that consisted of an individual completing twenty walking trials (twenty video clips-each clip represents one trial).
Participants were instructed to place their focus intently on the person performing the obstacle course and try to imagine themselves doing the skill.
Periodically, a reminder would appear to help focus and redirect participant's attention to different aspects of the video or different versions of imagery (visual or kinesthetic).
Participants will watch the video first at normal play speed and then in slow motion after a short break (30 secs to 1 min).
Total training time will be approximately 20 mins which is consistent with the duration of the locomotor intervention and duration of stimulation.
The participants received a 20-minute "active" session of tDCS at a 2-milliamp current.
|
Sham Comparator: MI/Sham tDCS
The participants received sham tDCS current and participated in the Motor Imagery intervention.
|
Participants watched a standardized video sequence that consisted of an individual completing twenty walking trials (twenty video clips-each clip represents one trial).
Participants were instructed to place their focus intently on the person performing the obstacle course and try to imagine themselves doing the skill.
Periodically, a reminder would appear to help focus and redirect participant's attention to different aspects of the video or different versions of imagery (visual or kinesthetic).
Participants will watch the video first at normal play speed and then in slow motion after a short break (30 secs to 1 min).
Total training time will be approximately 20 mins which is consistent with the duration of the locomotor intervention and duration of stimulation.
The participants received a 20-minute session of "sham" tDCS.
|
No Intervention: Control
The control group watched an unrelated (non stimulating) video for a duration equal to the MI groups' intervention tasks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prefrontal cortical activity
Time Frame: Baseline to 1 week follow up
|
Functional near infrared spectroscopy (fNIRS) monitor (OctaMon by Artinis Medical Systems), changes in oxygenated hemoglobin concentration (O2Hb) relative to a baseline task
|
Baseline to 1 week follow up
|
Adherence to interventions
Time Frame: Baseline to 1 week follow up
|
number of sessions attended
|
Baseline to 1 week follow up
|
Retention of participants
Time Frame: Baseline to 1 week follow up
|
number of participants completing intervention and follow-up assessment
|
Baseline to 1 week follow up
|
Adverse events in each study arm
Time Frame: Baseline to 1 week follow up
|
Number of unexpected and/or serious adverse events
|
Baseline to 1 week follow up
|
Time to completion
Time Frame: Baseline to 1 week follow up
|
Recorded time to complete the obstacle course
|
Baseline to 1 week follow up
|
Gait velocity
Time Frame: Baseline to 1 week follow up
|
Gait velocity, measured in meters/sec, was recorded using a zeno walkway gait analysis system.
ProtoKinetics Movement Analysis Software was used to collect and analyze the data.
|
Baseline to 1 week follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cognitive Assessment
Time Frame: Baseline to 1 week follow up
|
The Montreal Cognitive Assessment (MoCA) is a widely used screening tool designed to assess various cognitive domains, including memory, attention, language, visuospatial skills, executive function, and orientation.
During a MoCA test, individuals are presented with a series of tasks and questions that challenge different aspects of cognitive function.
These tasks may include remembering a list of words, drawing a certain shape, following complex instructions, and identifying similarities between words or objects.
|
Baseline to 1 week follow up
|
Kinesthetic and Visual Imagery Questionnaire (KVIQ)
Time Frame: Baseline to 1 week follow up
|
The ability to imagine movements was assessed with the Kinesthetic and Visual Imagery Questionnaire (KVIQ).
This test evaluates the subject's ability to see (visual imagery) and feel (kinesthetic imagery) movements.
The KVIQ consists of 10 items, (5 movements for each scale), each item being a separate movement followed by rating the ease or difficulty of generating those self-images on a 5-point Likert scale (where 1 = no image or sensation and 5 = Image as clear as seeing or as intense as executing the action).
Higher scores reflected higher imagery abilities.
|
Baseline to 1 week follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jared W Skinner, PhD, Appalachian State University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 20, 2022
Primary Completion (Actual)
December 22, 2022
Study Completion (Actual)
December 22, 2022
Study Registration Dates
First Submitted
May 3, 2024
First Submitted That Met QC Criteria
May 9, 2024
First Posted (Actual)
May 16, 2024
Study Record Updates
Last Update Posted (Actual)
May 16, 2024
Last Update Submitted That Met QC Criteria
May 9, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB-21-0198
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
There is not a plan to make Individual Participant Data (IPD) available.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Motor Learning
-
Kai Lutz, PhDUniversity of ZurichCompletedMotor Learning | Motor PerformanceSwitzerland
-
Sunnybrook Health Sciences CentreCompleted
-
Arizona State UniversityRecruiting
-
Institut National de la Santé Et de la Recherche...Not yet recruiting
-
Universidad Autonoma de MadridCentro Universitario La SalleUnknown
-
Universidad Autonoma de MadridCentro Universitario La SalleUnknown
-
Hospices Civils de LyonCompleted
-
Carrick Institute for Graduate StudiesCompletedGymnastics Injury, Motor Learning, BalanceUnited States
-
University of UtahCompletedBasic Motor Learning ProblemUnited States
-
Neuron, SpainRecruitingTranscranial Magnetic Stimulation | Motor LearningSpain
Clinical Trials on Motor Imagery (MI)
-
Hospices Civils de LyonRecruitingIndividuals With C6-C7 Tetraplegia (AIS A or B)France
-
I.R.C.C.S. Fondazione Santa LuciaUniversity of Roma La Sapienza; Istituto Superiore di SanitàCompleted
-
Reha RheinfeldenOxford Brookes UniversityCompleted
-
Biruni UniversityEnrolling by invitation
-
University of SalamancaRecruiting
-
Istanbul University - Cerrahpasa (IUC)Not yet recruiting
-
I.R.C.C.S. Fondazione Santa LuciaUniversity of Roma La SapienzaRecruitingSpinal Cord Injuries | Motor DisordersItaly
-
Georgia Institute of TechnologyNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
Abant Izzet Baysal UniversityRecruitingCerebral Palsy, SpasticTurkey
-
Ahmed Mahmoud KadryConcordia University WisconsinCompleted